(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Holiday Inn London - Regent's Park

Feb 01, 2016 8:00 AM - Feb 05, 2016 1:00 PM

Carburton Street , London, W1W 5EE, United Kingdom

Joint MHRA/DIA Excellence in Pharmacovigilance

This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements.

Back to Agenda

TOPIC 5 SESSION 5: Effectiveness of Risk Minimisation Measures

Session Chair(s)

Gaby L. Danan, MD, PhD

Gaby L. Danan, MD, PhD

Pharmacovigilance Expert

GLD, France

Phil Tregunno

Phil Tregunno

Deputy Director - Patient Safety Monitoring

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Speaker(s)

Jan Petracek, MD, MSc

Effectiveness of Risk Minimisation Measures

Jan Petracek, MD, MSc

Ivigee, Czech Republic

CEO

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.